WAVE Life Sciences' Series B Round

WAVE Life Sciences raised a round of funding on August 18, 2015.

WAVE Life Sciences is utilizing its synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause o…

Articles about WAVE Life Sciences' Series B Round: